As of Oct 02
| +0.37 / +2.81%|
The 6 analysts offering 12-month price forecasts for Aegerion Pharmaceuticals Inc have a median target of 24.50, with a high estimate of 38.00 and a low estimate of 9.00. The median estimate represents a +80.68% increase from the last price of 13.56.
The current consensus among 7 polled investment analysts is to Hold stock in Aegerion Pharmaceuticals Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.